These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10784616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.
    Ogawa M, Tsutsui T, Zou JP, Mu J, Wijesuriya R, Yu WG, Herrmann S, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1997 Jun 01; 57(11):2216-22. PubMed ID: 9187124
    [Abstract] [Full Text] [Related]

  • 5. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y, Yu WG, Mukai T, Gao P, Yamaguchi N, Murai M, Matsushima K, Obika S, Imanishi T, Higashibata Y, Nomura S, Kitamura Y, Fujiwara H, Hamaoka T.
    Cancer Res; 2002 Jul 01; 62(13):3751-8. PubMed ID: 12097285
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T, Seki S, Takeda K, Narita J, Ebe Y, Naito M, Hiraide H, Abo T.
    Cell Immunol; 1999 May 01; 193(2):219-25. PubMed ID: 10222065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C, Exley M, Balk S, Hohenberger W, Kuchroo VK.
    Eur J Immunol; 2001 Sep 01; 31(9):2818-28. PubMed ID: 11536181
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
    Denkers EY, Scharton-Kersten T, Barbieri S, Caspar P, Sher A.
    J Exp Med; 1996 Jul 01; 184(1):131-9. PubMed ID: 8691126
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Administration of IL-12 induces a CD3+ CD4- CD8- B220+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells.
    Tsutsui T, Mu J, Ogawa M, Yu WG, Suda T, Nagaga S, Saji F, Murata Y, Fujiwara H, Hamaoka T.
    J Immunol; 1997 Sep 15; 159(6):2599-605. PubMed ID: 9300678
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep 15; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of murine NK cells into distinct subsets based on variable expression of the IL-12R beta 2 subunit.
    Chakir H, Camilucci AA, Filion LG, Webb JR.
    J Immunol; 2000 Nov 01; 165(9):4985-93. PubMed ID: 11046026
    [Abstract] [Full Text] [Related]

  • 17. In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-.
    Launois P, Ohteki T, Swihart K, MacDonald HR, Louis JA.
    Eur J Immunol; 1995 Dec 01; 25(12):3298-307. PubMed ID: 8566015
    [Abstract] [Full Text] [Related]

  • 18. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z.
    Mol Immunol; 2005 May 01; 42(9):1023-31. PubMed ID: 15829292
    [Abstract] [Full Text] [Related]

  • 19. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
    Tomura M, Zhou XY, Maruo S, Ahn HJ, Hamaoka T, Okamura H, Nakanishi K, Tanimoto T, Kurimoto M, Fujiwara H.
    J Immunol; 1998 May 15; 160(10):4738-46. PubMed ID: 9590219
    [Abstract] [Full Text] [Related]

  • 20. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
    Moodycliffe AM, Maiti S, Ullrich SE.
    J Immunol; 1999 May 01; 162(9):5156-63. PubMed ID: 10227987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.